Antibody levels following vaccination against SARS-CoV-2 during an 11-month follow-up
Description
AIMS: The primary aim of our monitoring was to determine the duration of persistence of antibody levels following administration of the Comirnaty (Pfizer/BioNTech) mRNA vaccine. The second aim was to analyse the effect of selected factors on the
